Clinical trial
Safety of Intradermal Versus Intramuscular Administration of HIV Lipopeptides in…
NCT00121121 · French National Agency for Research on AIDS and Viral Hepatitis, Other · Completed
Key facts
| NCT number | NCT00121121 |
|---|---|
| Title | Safety of Intradermal Versus Intramuscular Administration of HIV Lipopeptides in HIV Uninfected Adult Volunteers |
| Official title | A Phase Ib Vaccine Trial Evaluating the Safety and Immunogenicity of HIV Lipopeptides by Two Administration Routes (Intramuscular And Intradermal) in Healthy Adult Volunteers. ANRS VAC16 Trial |
| Lead sponsor | French National Agency for Research on AIDS and Viral Hepatitis, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infections, HIV Seronegativity |
| Intervention type | Biological |
| Interventions | Lipopeptides LIPO-4 |
| Enrollment | 70 |
| Start date | Jul 1, 2004 |
| Completion | Dec 1, 2005 |
| First posted | Jul 21, 2005 |
| Last update posted | Mar 15, 2007 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: